Addex Therapeutics ADXN
NASDAQ ADXN
$2.96 +0.22 (+8.03%)
At close: Nov 10, 2026 · 4:00 PM EST

Addex Therapeutics (ADXN) Current Deferred Revenue (2019 - 2023)

Updated

Addex Therapeutics (ADXN) reported Current Deferred Revenue of $264,903 for Q4 2023.

Analysis

Addex Therapeutics (ADXN) Current Deferred Revenue (2019 - 2023) Analysis & Trends

Dating back to Q4 2018, Addex Therapeutics' Current Deferred Revenue record includes 8 quarters.

  • Current Deferred Revenue has a five-year compound annual growth rate of 4.4% (FY2018 to FY2023).
  • By year, Current Deferred Revenue came in at $95,661 in FY2020 (-42.8%) and $167,106 in FY2019 (-21.8%).
  • The Q4 2023 figure ranks as the highest quarterly Current Deferred Revenue in data going back to Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Addex Therapeutics 3.65 Mn -3.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 278,621.22
Mar 31, 2021 14,191.51
Dec 31, 2020 98,097.74
Sep 30, 2020 163,077.53
Jun 30, 2020 231,294.89
Mar 31, 2020 185,106.26
Dec 31, 2019 341,491.59
API Access

Addex Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ADXN&period=max&api_key=YOUR_API_KEY